Cargando…

SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist

Cystic fibrosis (CF) is a genetic, life-limiting disease without a cure; treatment is complex and lifelong. Respiratory failure is the most common cause of death; however, gastrointestinal disease, diabetes and liver disease are common comorbidities. Coronavirus disease (COVID-19) rapidly changed he...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunk, Rachel, Madge, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520593/
https://www.ncbi.nlm.nih.gov/pubmed/34642180
http://dx.doi.org/10.1136/bmjoq-2021-001427
_version_ 1784584701741105152
author Dunk, Rachel
Madge, Susan
author_facet Dunk, Rachel
Madge, Susan
author_sort Dunk, Rachel
collection PubMed
description Cystic fibrosis (CF) is a genetic, life-limiting disease without a cure; treatment is complex and lifelong. Respiratory failure is the most common cause of death; however, gastrointestinal disease, diabetes and liver disease are common comorbidities. Coronavirus disease (COVID-19) rapidly changed healthcare services across the globe, including redeployment of healthcare professionals. This adult CF service was challenged to continue a patient facing service within severe staffing and structural limitations. Not only were many members of the CF multidisciplinary team (MDT) redeployed at the start of the first wave, but also both the CF and ambulatory care wards were closed. Fortunately, the CF clinical nurse specialists (CF-CNSs) remained in their role. Rapid change and adaptation of the CF service was required to ensure that patients did not feel abandoned and access to treatment remained available. The role of the CF-CNS was therefore pivotal in this change. The aim of this project was to use quality improvement methodology to plan an emergency service allowing a reintroduction of ambulatory care services. Success was measured by the number of patients clinically reviewed with or without intervention, and the reasons for patients contacting the CF-CNS via email and phone were recorded. In weeks 1 and 2 of the emergency service, the CF-CNSs triaged patients by phone, then reviewed face-to-face when necessary. This first step allowed the CF-CNSs to start two patients on home intravenous antibiotics. This service continued to be developed over the following 12 weeks, leading to a total of 36 patient attendances. In March 2020, n=1187 patients made contact (mostly COVID-19, unwell and medication related), in April n=904 and May n=870 (blood test results, unwell and medication related). The motivation of the CF-CNSs was pivotal to the success of this initiative with the CF MDT available to provide some support and advice. It concluded at week 12, which then saw the opening of the formal ambulatory care ward and returning redeployed ward staff.
format Online
Article
Text
id pubmed-8520593
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85205932021-10-19 SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist Dunk, Rachel Madge, Susan BMJ Open Qual Quality Improvement Report Cystic fibrosis (CF) is a genetic, life-limiting disease without a cure; treatment is complex and lifelong. Respiratory failure is the most common cause of death; however, gastrointestinal disease, diabetes and liver disease are common comorbidities. Coronavirus disease (COVID-19) rapidly changed healthcare services across the globe, including redeployment of healthcare professionals. This adult CF service was challenged to continue a patient facing service within severe staffing and structural limitations. Not only were many members of the CF multidisciplinary team (MDT) redeployed at the start of the first wave, but also both the CF and ambulatory care wards were closed. Fortunately, the CF clinical nurse specialists (CF-CNSs) remained in their role. Rapid change and adaptation of the CF service was required to ensure that patients did not feel abandoned and access to treatment remained available. The role of the CF-CNS was therefore pivotal in this change. The aim of this project was to use quality improvement methodology to plan an emergency service allowing a reintroduction of ambulatory care services. Success was measured by the number of patients clinically reviewed with or without intervention, and the reasons for patients contacting the CF-CNS via email and phone were recorded. In weeks 1 and 2 of the emergency service, the CF-CNSs triaged patients by phone, then reviewed face-to-face when necessary. This first step allowed the CF-CNSs to start two patients on home intravenous antibiotics. This service continued to be developed over the following 12 weeks, leading to a total of 36 patient attendances. In March 2020, n=1187 patients made contact (mostly COVID-19, unwell and medication related), in April n=904 and May n=870 (blood test results, unwell and medication related). The motivation of the CF-CNSs was pivotal to the success of this initiative with the CF MDT available to provide some support and advice. It concluded at week 12, which then saw the opening of the formal ambulatory care ward and returning redeployed ward staff. BMJ Publishing Group 2021-10-12 /pmc/articles/PMC8520593/ /pubmed/34642180 http://dx.doi.org/10.1136/bmjoq-2021-001427 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
Dunk, Rachel
Madge, Susan
SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist
title SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist
title_full SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist
title_fullStr SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist
title_full_unstemmed SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist
title_short SARS-CoV-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist
title_sort sars-cov-2 driving rapid change in adult cystic fibrosis services: the role of the clinical nurse specialist
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520593/
https://www.ncbi.nlm.nih.gov/pubmed/34642180
http://dx.doi.org/10.1136/bmjoq-2021-001427
work_keys_str_mv AT dunkrachel sarscov2drivingrapidchangeinadultcysticfibrosisservicestheroleoftheclinicalnursespecialist
AT madgesusan sarscov2drivingrapidchangeinadultcysticfibrosisservicestheroleoftheclinicalnursespecialist